January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

In people with PA and no concerning features, treatment with high-dose oral B12 or injection B12 are both reasonable options.

A person who has the type of anemia with B12 deficiency and low B12 levels (called "megaloblastic anemia" with unusual white ...

Dear M.P.: Pernicious anemia (PA) is an autoimmune disease where the body destroys the cells in the stomach that make ...

Researchers have a new hope for preventing severe illness from the bird flu after finding a groundbreaking antibody treatment ...

I am 71 years old and was diagnosed with pernicious anemia in October 2024. My B12 and folate levels were low. My antiparietal antibodies were abnormal, but the ...

So, we now have multiple new classes of drugs, multiple agents that are FDA-approved for the treatment of multiple myeloma, more than 15, 16 different drugs that have become available in that period.

In this video, Sham Mailankody, MBBS discusses the current state of the pipeline for developing multiple myeloma treatments.

The patient has iMCD, which has a poor survival rate and few treatment options but an AI tool searched through 4,000 ...

Lung transplant recipients are highly susceptible to infection, the researchers noted, and P. aeruginosa is a leading cause of bacterial pneumonia for them. Indeed, it was the most frequently isolated ...

Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

IDEFIRIX Product Sales Increased 83% Compared to the Prior Year LUND, Sweden, Feb. 6, 2025 /PRNewswire/ -- Hansa Biopharma AB, Hansa or the Company ...